About > News

Harbour BioMed Acquires Harbour Antibodies to Create Global, Oncology-focused Biotechnology Company

Harbour BioMed Acquires Harbour Antibodies to Create Global, Oncology-focused Biotechnology Company Transgenic Mouse Platform Technology Licensing to Continue, Expand to Include Collaborative Discovery/Development Partnerships December 19, 2016 09:00 AM Eastern Standard Time CAMBRIDGE, Mass. & SHANGHAI & ROTTERDAM, The Netherlands–(BUSINESS WIRE)–Harbour BioMed, a recently established Shanghai-based company, today announced it has acquired Harbour Antibodies BV for cash and an equity interest in Harbour BioMed to create a new, global oncology-focused biotechnology company. The new company plans to leverage Harbour Antibodies’ patented transgenic mouse platforms to build an internal portfolio of next generation therapeutic antibodies for cancer, expand the range of partnerships and licenses around Harbour’s platforms, and capitalize on the …

IBC Antibody Engineering and Therapeutics, Decemeber 11-15, San Diego

Decmeber 11-15, IBC Antibody Engineering and Therapeutics in San Diego

Protein & Antibody Engineering Summit, October 31-November 4, Lisbon

October 31-November 4,  Protein & Antibody Engineering Summit in Lisbon

Harbour Antibodies Announces 25th License to Its Transgenic Mouse Platforms for Next Generation Monoclonal Antibody Discovery

Harbour Antibodies Announces 25th License to Its Transgenic Mouse Platforms for Next Generation Monoclonal Antibody Discovery  Licenses Highlight Increasing Recognition of Platforms’ Potential   Rotterdam, The Netherlands and Cambridge, MA, September 18, 2015 – Harbour Antibodies BV today announced the signing of five new licenses to the company’s patented transgenic mouse platforms to discover next generation, high affinity, therapeutic human antibody products. These new licenses bring to 25 the total number of licenses by pharma and biotech companies, as well as academic organizations. The recent group of licensees includes MD Anderson Cancer Center and several international biotech companies and includes licenses to Harbour’s heavy chain only and conventional antibody generating …

Harbour News

Upcoming Events

Contact Us

Name: 
Email: 
Company: 
Message: 
Submit

Join Mailing List

Name: 
Email: 
Company: 
Submit